Search Results 291-300 of 17580 for what is vedolizumab

  1. Diarrhea - Mayo Clinic

    Chronic diarrhea can indicate a serious disorder, such as ulcerative colitis or Crohn's disease, or a less serious condition, such as irritable bowel syndrome.

  2. Ustekinumab-kfce (intravenous route, subcutaneous route) - Mayo Clinic

    Ustekinumab-kfce injection is also used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

  3. Convergence Science Program Archives - Mayo Clinic News Network

    ... ulcerative colitis, which causes ulcers, or sores, in the lining of the large intestine and rectum, and Crohn's disease, which causes inflammation of the ...

  4. Sharing Mayo Clinic: Lifting the weight of debilitating inflammatory bowel disease

    Ulcerative colitis and Crohn's disease are the two main types. Marissa began experiencing symptoms of inflammatory bowel disease when she was in her early ...

  5. Mayo Clinic Q&A: What does an IBD diagnosis mean for me?

    Ulcerative colitis typically affects the colon and rectum, and it leads to the development of sores called ulcers. Crohn's disease primarily affects the small ...

  6. A Study of the Relationship Between Infliximab Levels and the Rate of Colectomies in Patients who have Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to assess if infliximab drug levels in patients who have Ulcerative Colitis predict the risk of needing a colectomy. Additionally, ...

  7. Ustekinumab-srlf (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Ustekinumab-srlf injection is also used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

  8. Mucus in stool: A concern? - Mayo Clinic

    Bloody mucus in stool or mucus along with belly pain may signal a more serious condition, such as Crohn's disease, ulcerative colitis and even cancer. There ...

  9. Publications - Talha A. Malik, M.D. - Mayo Clinic

    Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory ...

  10. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... vedolizumab at a dose approved for the treatment of UC and failed to respond to or tolerate such treatment; Is naïve to biologic therapy (TNF antagonists or ...